IT1216787B - Immunosoppressori contenenti derivati della chinolina - Google Patents

Immunosoppressori contenenti derivati della chinolina

Info

Publication number
IT1216787B
IT1216787B IT8747586A IT4758687A IT1216787B IT 1216787 B IT1216787 B IT 1216787B IT 8747586 A IT8747586 A IT 8747586A IT 4758687 A IT4758687 A IT 4758687A IT 1216787 B IT1216787 B IT 1216787B
Authority
IT
Italy
Prior art keywords
immunospressors
quinoline derivatives
containing quinoline
derivatives
quinoline
Prior art date
Application number
IT8747586A
Other languages
English (en)
Other versions
IT8747586A0 (it
Inventor
Larson Douglas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8747586A0 publication Critical patent/IT8747586A0/it
Application granted granted Critical
Publication of IT1216787B publication Critical patent/IT1216787B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT8747586A 1986-01-31 1987-01-30 Immunosoppressori contenenti derivati della chinolina IT1216787B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602372A GB8602372D0 (en) 1986-01-31 1986-01-31 Organic compounds

Publications (2)

Publication Number Publication Date
IT8747586A0 IT8747586A0 (it) 1987-01-30
IT1216787B true IT1216787B (it) 1990-03-14

Family

ID=10592282

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8747586A IT1216787B (it) 1986-01-31 1987-01-30 Immunosoppressori contenenti derivati della chinolina

Country Status (14)

Country Link
EP (1) EP0231151A3 (it)
JP (1) JPS62190123A (it)
KR (1) KR870007126A (it)
AU (1) AU6812387A (it)
BE (1) BE1002394A3 (it)
DE (1) DE3701891A1 (it)
DK (1) DK47687A (it)
FR (1) FR2595571A1 (it)
GB (2) GB8602372D0 (it)
IE (1) IE870228L (it)
IT (1) IT1216787B (it)
NL (1) NL8700191A (it)
SE (1) SE8700361L (it)
ZA (1) ZA87712B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8702680A (nl) * 1986-11-21 1988-06-16 Sandoz Ag Nieuwe benzogchinolinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
DE102005041613A1 (de) * 2005-09-01 2007-03-08 Ergonex Pharma Gmbh Pharmazeutische Zusammensetzungen zur Behandlung von Karzinoid-Syndrom

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867534A (en) * 1972-08-07 1975-02-18 Upjohn Co Dosage regimen
US3928612A (en) * 1974-10-02 1975-12-23 American Home Prod 1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents
US4225600A (en) * 1977-05-04 1980-09-30 Fisons Limited Compositions and methods for treating certain skin conditions
CH632161A5 (it) * 1978-01-17 1982-09-30 Siphar Sa Composizione farmaceutica per il trattamento dell'asma.
DE3247514A1 (de) * 1982-12-20 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Zytostatisch wirkende kombination
GB8422253D0 (en) * 1984-09-04 1984-10-10 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
KR870007126A (ko) 1987-08-14
JPS62190123A (ja) 1987-08-20
EP0231151A2 (en) 1987-08-05
DK47687A (da) 1987-08-01
NL8700191A (nl) 1987-08-17
SE8700361D0 (sv) 1987-01-30
IE870228L (en) 1987-07-31
GB2185886A (en) 1987-08-05
FR2595571A1 (fr) 1987-09-18
AU6812387A (en) 1987-08-06
SE8700361L (sv) 1987-08-01
DK47687D0 (da) 1987-01-29
EP0231151A3 (en) 1990-04-11
ZA87712B (en) 1988-09-28
DE3701891A1 (de) 1987-08-13
GB8701847D0 (en) 1987-03-04
GB8602372D0 (en) 1986-03-05
BE1002394A3 (fr) 1991-01-29
IT8747586A0 (it) 1987-01-30

Similar Documents

Publication Publication Date Title
DK263587A (da) Imidazoquinolinyletherderivater
DK82087A (da) Pyrocatecholderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
DK69887A (da) Dichloranilinderivater
DK47787D0 (da) Dihydropyridinderivatholdige retardpraeparater
DK693587D0 (da) Alkansulfonanilidderivater
IT1150203B (it) Derivati della naftiridina
DK300887D0 (da) Dihydropyridinderivater
DK81888D0 (da) Dibenzoxepinderivater
IT1187714B (it) Tenisoattivi derivati da idrossiacidi bicarbossilici
IT1231238B (it) Derivati ammidinici
DK691287D0 (da) 5-floururacilderivater
DK210487A (da) Substituerede benzimidazolderivater
DK15686A (da) Dihydropyridinderivater
IT8620667A0 (it) Derivati della chinolina
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
IT1216787B (it) Immunosoppressori contenenti derivati della chinolina
IT1164218B (it) Derivati della aleteina
IT1179549B (it) Derivati della 2-aribenzotiazolina
DK440687A (da) Bicyclooctanderivater
DK619187A (da) Isoindolderivater
DK229887D0 (da) Alkenamidderivater
IT1222154B (it) Derivati della taurina
DK435087A (da) Isoprenderivater
IT1157284B (it) Derivati della cistina